Contracts and maturing homes power EBITDA at Avery Healthcare

Avery Healthcare reported rising turnover and EBITDA as it benefited from new care home management contracts and ‘maturing’ settings across the group. Turnover for the year ended 31 March 2024 rose 50.1% to £296.1m (2023: £197.3m), while cost of sales grew 67.9% to £178.6m (2023: £106.4m) and administrative expenses went up 3% to £109.7m (2023:…

Membership Required

You must be a CM Subscriber to view this content.

Subscribe Now »

Already have an account?